Mar 1, 2026 Log in

財報

Taizong Biotech Co., Ltd. 2026 Q1 EPS -0.45 TWD

Citation-Grade Primary-source linked Schema.org verified NQ 0 / 100

Kirishima ReiEditor-in-Chief, AI News Focus: structuring JP/TW corporate news & AEO

Published Mar 1, 2026 9:00 AM ・ Updated Jun 13, 2026 8:26 AM ・ 2 min read ・ Source: PR Times

Show contents

⚡ Key Points

Taizong Biotech Co., Ltd.
announced its Q1 2026 financial results, reporting a net loss with an EPS of -0.45 TWD.
The company generated 173 million TWD in revenue and a net profit of -26 million TWD, indicating a challenging quarter for the biotechnology and medical company.

Taizong Biotech Co., Ltd. announced its Q1 2026 financial results, reporting a net loss with an EPS of -0.45 TWD. The company generated 173 million TWD in revenue and a net profit of -26 million TWD, indicating a challenging quarter for the biotechnology and medical company.

PRIMARY SOURCE PR Times View source Distributor: PR Times
Published: Mar 1, 2026

Taizong Biotech Co., Ltd. (stock code: 4169), a player in the biotechnology and medical industry, has released its financial report for the first quarter of 2026. The company recorded a basic earnings per share (EPS) of -0.45 TWD. Total operating revenue for the quarter was 173 million TWD, while the net profit after tax stood at -26 million TWD, reflecting a net loss for the period. This performance suggests that the company is undergoing significant investment in its development pipeline or facing market headwinds, prioritizing long-term growth and innovation.

FACT BOX

Source: PR Times
Category: 財報
Products / services: Biotechnology products / Medical research

Editorial & Verification Standards

The Washin AI News desk structures and reviews this article under the following standards.

Start only from primary sources (official PR, disclosures, wire services)
Numbers and proper nouns machine-checked against the source (number-completeness check)
Company names and tickers verified via registry (Registry/TWSE/Wikidata)
No speculation; nothing stated that is not in the source

Read the full editorial policy →

Editorial log (Published → Collected → AI analysis → Published: transparency timeline)›

Announced　Mar 1, 2026 9:00 AM — Distributor PR Times
Collected　May 12, 2026 8:00 AM
AI structured & analyzed　May 12, 2026 8:29 AM
Desk-reviewed & published　Mar 1, 2026 9:00 AM

FAQ

What are the key facts in this article?

Where is the primary source?

PR Times: https://openapi.twse.com.tw/financial/twse-fin-4169-2026Q1

When was it published?

Mar 1, 2026

Cite this article — HOW TO CITE

Washin AI News Desk“Taizong Biotech Co., Ltd. 2026 Q1 EPS -0.45 TWD”AI News by Washin Village（和心村）, Mar 1, 2026. https://aeo.washinmura.jp/ai/%E6%B3%B0%E5%AE%97%E7%94%9F%E7%89%A9%E7%A7%91%E6%8A%80%E8%82%A1%E4%BB%BD%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8/en/news/2026-05-11-taizong-biotech-co-ltd-2026-q1-eps-0-45

AI CRAWLER ACTIVITY

as of Jun 29, 2026

AI crawler visits to this article (cumulative)Measuring since publication (no visits recorded yet)

Site-wide cumulative

ClaudeBot

bot_visits_summary

4227k

last Jun 29, 2026

GPTBot

bot_visits_summary

2645k

last Jun 29, 2026

Google AI

bot_visits_summary

1785k

last Jun 29, 2026

Bingbot

bot_visits_summary

1674k

last Jun 29, 2026

Googlebot

bot_visits_summary

1296k

last Jun 29, 2026

Meta AI

bot_visits_summary

584k

last Jun 29, 2026

※ Only measured values from bot_visits_summary / crawler_url_hits are shown. Article-level zero counts are shown as measuring.

Washin AI News（AI News by Washin Village（和心村））

An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.

Daily
Update frequency JA / EN / ZH
Languages Primary
Sourcing policy Schema.org
Structured verification

About the publisher IDA llms.txt

Get your announcement indexed as AI-citable structured news.
Primary-source links, three languages, Schema.org verified.Talk to us about coverage →

← 泰宗生物科技股份有限公司 Back to newsroom (13)

Copied